Choose Your Language:
Posted by: The Sumaira Foundation in News & Announcements
August 11, 2025 – The Sumaira Foundation (TSF) is pleased to welcome Randi Griffin to our team as a research associate.
Randi brings 6+ years of clinical research experience in global Phase II-IV trials across neurology, oncology and rare diseases to The Sumaira Foundation. A Duke University neuroscience graduate, Randi has driven protocol compliance and operational excellence at leading organizations including IQVIA, St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center. With deep expertise in neurological clinical trials and ICH/GCP-compliant trial management, he is passionate about advancing research that brings hope to underserved patient communities facing rare neuroimmune conditions like NMOSD and MOGAD.
Joining TSF means becoming part of a patient-powered movement that illuminates the darkness of rare neuroimmune conditions. Having managed clinical trials in neurology, I’ve witnessed firsthand the urgent need for research and support in conditions like NMOSD and MOGAD. I’m honored to contribute my clinical research expertise to an organization that not only advances critical science but also builds global communities of hope for patients and families navigating these challenging diagnoses. TSF’s commitment to being truly patient-led and science-driven aligns perfectly with my passion for research that transforms lives.
– Randi Griffin, TSF Research Associate
